Indicator summary: Neutral (2 bullish, 2 bearish, 1 neutral). As of 2026-11-05, the close was $264.88: 0.5% below the 50-day average and 26.1% above the 200-day average, which is rising. RSI (14) is 48, in its neutral range. MACD is bearish after a cross in the last 10 days. The stock sits 85% of the way up its 52-week range of $154.50 to $284.50, on 1.3x its 20-day average volume.
| Indicator | Reading | Read |
|---|---|---|
| 50-day average | $266.26 | Price 0.5% below |
| 200-day average | $210.00 | Price 26.1% above, average rising |
| 50 vs 200-day | 50 above 200 | Golden-cross alignment |
| RSI (14) | 48 | Neutral range |
| MACD (12, 26, 9) | +0.39 vs +1.82 | Bearish cross in the last 10 days |
| 52-week range | $154.50 to $284.50 | 85% of the way up the range |
| Volume vs 20-day average | 1.3x | Normal |
Base rates use IQV's own daily history since 2013; they describe the past, not a forecast.
As of 2026-11-05, IQV's 14-day RSI is 48, which is in the neutral range between 30 and 70.
Yes. IQV closed at $264.88 on 2026-11-05, 26.1% above its 200-day average of $210.00, which is rising. When it closed above its 200-day average (2,166 days), it was higher 63 trading days later 64% of the time, median +4.5%.
No. IQV closed at $264.88 on 2026-11-05, 0.5% below its 50-day average of $266.26. When it closed below its 50-day average (1,243 days), it was higher 63 trading days later 70% of the time, median +7.5%.
Yes, a bearish cross within the last 10 trading days. As of 2026-11-05 the MACD line is +0.39 against a signal line of +1.82, so MACD is bearish.
No. At $264.88 it sits 85% of the way up its 52-week range of $154.50 to $284.50, 6.9% below the high.
Neutral: 2 of 5 indicators are bullish and 2 bearish as of 2026-11-05 (the 50 and 200-day averages, their alignment, RSI and MACD). A rating summarises the chart; it is not a recommendation.
ŷRobot chart signal: Hold, from the chart signal model.
IQV analysis: AI score, fair value and forecast · Is it a bull or a bear market today? · All covered stocks
ŷRobot analysis is AI-generated and quality-gated; nothing here is investment advice.